Latest From TransMedics Inc.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the US FDA's approval of a panel-track supplement for TransMedics' OCS Lung system to preserve donor lungs that would not be salvageable using a traditional cold static system.
FDA approved a PMA supplement to allow TransMedics' Organ Care System (OCS) to be used for the preservation and ex-vivo assessment of lungs that would not be acceptable for transplant if they had been preserved with a standard cold static system.
Paragonix Technologies, which developed the first CE-marked and US FDA-cleared medical device system for transporting donor hearts, is ramping-up marketing in Europe and the US while continuing to expand its technology platform to kidney and lung transplants.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker.
- Medical Devices
- Therapeutic Areas
- Hepatic (Liver)
- Immune Disorders
- North America
- Parent & Subsidiaries
- TransMedics Inc.
- Senior Management
Waleed Hassanein, MD, Pres. & CEO
Stephen Gordon, CFO
Tamer Khayal, MD, Chief Commercial Officer
- Contact Info
Phone: (978) 552-0900
200 Minuteman Rd.
Andover, MA 01810
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.